Saturday, August 18, 2018
 
 
Company News: Page (1) of 1 - 06/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Taconic Biosciences Launches European Production of Diet Induced Obesity Model

(June 13, 2018)

RENSSELAER, N.Y., June 13, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has launched local production of the Taconic diet induced obesity (DIO) model in Europe. 

DIO mice are used to study metabolic disease and obesity because they exhibit elevated glucose, insulin, cholesterol, leptin, and corticosterone, thus mimicking many aspects and complications of human metabolic disease. The Diet Induced Obese (DIO) C57BL/6NTac remains a preferred metabolic model because when placed on a high fat diet, C57BL/6NTac develops more consistent and pronounced metabolic syndrome compared to other DIO models.

“Taconic’s commitment to providing its customers with the best animal model solutions means providing access to technically superior products.  Having local production for the European research community enables scientists to easily leverage the C57BL/6NTac for critical studies,” stated Dr. Megan MacBride, portfolio director for commercial models at Taconic. Taconic’s DIO mice will be available for immediate delivery in typical study sizes, saving researchers months of conditioning time, and allowing them to start studies faster.

Taconic has an extensive collection of genetically engineered models (GEMs) and non-genetically engineered models as well as custom model generation and colony management solutions.  To learn more about Taconic's products and services, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email [email protected]

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Kelly Owen Grover

Director of Marketing Communications

(518) 697-3824

[email protected]


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines